BACKGROUND: The transformation of smooth muscle cells (SMCs) into alternative phenotypes is a key process in atherosclerosis pathogenesis. Recent studies have revealed oncological parallels between atherosclerosis and cancer, such as DNA damage and oncogenic pathway activation in SMCs, but the precise molecular mechanisms remain poorly understood. This study integrates cancer gene sets using bioinformatics to identify key hub genes associated with atherosclerosis and explores their immune molecular mechanisms. METHODS: Datasets from the Gene Expression Omnibus (GEO) were analyzed to identify differentially expressed genes (DEGs) and module genes using Limma and WGCNA. Machine learning algorithms (SVM-RFE, LASSO regression, and random forest) were employed to identify cancer-related hub genes for early atherosclerosis diagnosis. A diagnostic model was constructed and validated. UMAP plots from single-cell RNA sequencing data were used to analyze the expression patterns of hub genes, particularly focusing on macrophage-like SMCs in SMC lineage-traced mouse models. Biomarker expression was validated in both human and mouse experiments. RESULTS: Four cancer-related hub genes (CRGs) were identified: Interferon Regulatory Factor 7 (IRF7), Formin Homology 2 Domain Containing 1 (FHOD1), Tumor Necrosis Factor (TNF), and Zinc Finger SWIM Domain Containing 3 (ZSWIM3). A diagnostic nomogram using IRF7, FHOD1, and TNF demonstrated high accuracy and reliability in both training and validation datasets. Immune microenvironment analysis revealed significant differences between atherosclerosis and control groups. Spearman correlation analysis highlighted associations between hub genes and immune cell infiltration. Single-cell RNA sequencing identified distinct SMC-derived cell clusters and phenotypic transitions, with increased expression of IRF7 and FHOD1 in macrophages potentially derived from SMCs in both human carotid plaques and mouse models. CONCLUSION: This study integrates cancer gene sets to identify key hub genes in atherosclerosis, emphasizing its parallels with cancer. The diagnostic nomogram based on IRF7, FHOD1, and TNF provides a reliable tool for early diagnosis, while insights into SMC phenotypic switching and immune microenvironment modulation offer potential therapeutic targets.
Athero-oncology perspective: identifying hub genes for atherosclerosis diagnosis using machine learning.
动脉粥样硬化肿瘤学视角:利用机器学习识别动脉粥样硬化诊断的关键基因。
阅读:6
| 期刊: | Frontiers in Immunology | 影响因子: | 5.900 |
| 时间: | 2025 | 起止号: | 2025 Nov 4; 16:1616096 |
| doi: | 10.3389/fimmu.2025.1616096 | 研究方向: | 肿瘤 |
| 疾病类型: | 动脉粥样硬化 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。